Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes

[1]  P. Jänne,et al.  Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non-Small-Cell Lung Cancer. , 2016, JAMA oncology.

[2]  K. Lillemoe,et al.  Branch Duct Intraductal Papillary Mucinous Neoplasms: Does Cyst Size Change the Tip of the Scale? A Critical Analysis of the Revised International Consensus Guidelines in a Large Single-Institutional Series , 2013, Annals of surgery.

[3]  Koichi Suda,et al.  Cystic Neoplasm of the Pancreas: A Japanese Multiinstitutional Study of Intraductal Papillary Mucinous Tumor and Mucinous Cystic Tumor , 2004, Pancreas.

[4]  V. Jobanputra,et al.  The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes , 2016, Modern Pathology.

[5]  T. Kawabe,et al.  Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression , 2012, Journal of Gastroenterology.

[6]  Y. Yatabe,et al.  GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas , 2015, Virchows Archiv.

[7]  G. Klöppel,et al.  Intraductal papillary neoplasms of the pancreas. A clinicopathologic study of six patients , 1989, Cancer.

[8]  Masakazu Yamamoto,et al.  Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas , 2011, Scientific reports.

[9]  K. Yamaguchi,et al.  Mucin-hypersecreting tumor of the pancreas with mucin extrusion through an enlarged papilla. , 1991, The American journal of gastroenterology.

[10]  D. Gouma,et al.  Prevalence of Pancreatic Cysts Detected by Screening Magnetic esonance Imaging Examinations , 2022 .

[11]  K. Yamao,et al.  Mucin‐producing tumor of the pancreas , 1991, Cancer.

[12]  M. Farnell,et al.  Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. , 2008, Archives of surgery.

[13]  K. Kinzler,et al.  Clinicopathological Correlates of Activating GNAS Mutations in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas , 2013, Annals of Surgical Oncology.

[14]  J. Sahel,et al.  Villous adenoma of the main pancreatic duct: a potentially malignant tumor? , 1990, The American journal of gastroenterology.

[15]  K. Lillemoe,et al.  Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis. , 2015, Journal of the American College of Surgeons.

[16]  Rita T Lawlor,et al.  Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas , 2014, The Journal of pathology.

[17]  Masao Tanaka,et al.  Management of pancreatic cysts: the evidence is not here yet. , 2015, Gastroenterology.

[18]  K. Lillemoe,et al.  Intraductal Papillary Mucinous Neoplasms , 2007 .

[19]  J. DeWitt,et al.  Smoking and IPMN malignant progression. , 2017, American journal of surgery.

[20]  Olca Basturk,et al.  Pathologically and Biologically Distinct Types of Epithelium in Intraductal Papillary Mucinous Neoplasms: Delineation of an “Intestinal” Pathway of Carcinogenesis in the Pancreas , 2004, The American journal of surgical pathology.

[21]  Masakazu Yamamoto,et al.  Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas , 2010, Gut.

[22]  M. Berger,et al.  GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma. , 2015, Journal of the American College of Surgeons.

[23]  A. Maitra,et al.  Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development , 2011, Science Translational Medicine.

[24]  Masakazu Yamamoto,et al.  Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms , 2011, The Journal of pathology.

[25]  N. Rofsky,et al.  Prevalence of Incidental Pancreatic Cysts in the Adult Population on MR Imaging , 2010, The American Journal of Gastroenterology.

[26]  Jihye Kim,et al.  Emerging transcriptional landscape and putative therapeutic targets in young patients with metastatic colorectal cancer (CRC). , 2015 .

[27]  Jin-Young Jang,et al.  International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. , 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[28]  K. Lillemoe,et al.  Outcomes of Primary Surveillance for Intraductal Papillary Mucinous Neoplasm , 2011, Journal of Gastrointestinal Surgery.

[29]  D. Sahani,et al.  Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes , 2011, Gut.

[30]  C. Sotiriou,et al.  Genomic aberrations in young and elderly breast cancer patients , 2015, BMC Medicine.

[31]  S. Chari,et al.  International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas , 2006, Pancreatology.

[32]  A. Levy.  Prevalence of Unsuspected Pancreatic Cysts on MDCT , 2009 .